the role and clinical use of tpo receptor agonists in the treatment of itp
Published 1 year ago • 142 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
4:14
long-term safety and efficacy of sutimlimab for chronic itp
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
2:38
the management of itp during and after the covid-19 pandemic
-
1:53
avatrombopag: a novel oral therapy for the treatment of itp
-
6:48
lenalidomide and eltrombopag in patients with low or intermediate-risk mds with thrombocytopenia
-
1:06:04
itp: novel treatments
-
4:13
clinical manager interview: thrombolysis pathway
-
8:57
outcomes of sct in t-all and t-lbl
-
1:19
the potential of caplacizumab in the treatment of attp
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:29
the role of the multidisciplinary team in providing adequate diagnosis & treatment for bpdcn
-
0:45
difference between quality of life & patient-reported outcomes
-
1:09
the role of allosct in lbcl in the era of car-t
-
0:44
the role of allosct for r/r lbcl in the era of car-t therapy
-
0:57
the potential of the tsafinder tool in hematological oncology
-
3:16
cd-7 targeted car-t therapy in heavily pretreated patients with aml: a phase i trial
-
3:02
real-world analysis of safety and efficacy of romiplostim for itp